NetworkNewsBreaks Archive - Page 3 of 690

WednesdayApr 01, 2020 2:40 pm

NetworkNewsBreaks – Sharing Services Global Corporation (SHRG) Subsidiary Successfully Launches New ElevaciTea(TM), Surpasses Prior Presale Record

Diversified holdings company Sharing Services Global Corporation (OTCQB: SHRG), through its Elevacity LLC subsidiary, recently launched ElevaciTea(TM) (http://nnw.fm/w11zX). The company reported that the limited-edition vanilla-chai nootropic tea product’s two-day presale surpassed all SHRG’s previous product launches. An article discussing the company reads, “ElevaciTea, also called Happy Tea, is the newest product in Elevacity’s nootropic line. Nootropics are an all-natural blend of amino acids, choline and fat burners believed to improve cognitive function such as memory, creativity and/or motivation in healthy individuals. Elevacity promotes its nootropics line as an optimal formula to help deliver and elevate happiness hormones. This new tea is…

WednesdayApr 01, 2020 11:42 am

NetworkNewsBreaks – U.S. Gold Corp. (NASDAQ: USAU) Announces $2M Registered Direct Offering

U.S. Gold (NASDAQ: USAU) on Monday announced its entry into a securities purchase agreement with certain institutional investors, providing for the purchase and sale of 357,143 shares of common stock, each at a price of $5.60, in a registered direct offering, resulting in total gross proceeds of $2.0 million. According to the update, U.S. Gold also agreed to issue unregistered warrants to the investors in a concurrent private placement to purchase up to 1 share of common stock for each share of common stock purchased with an exercise price of $7.00 per share. The warrants will be exercisable six months…

WednesdayApr 01, 2020 10:59 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Financial Results for Full-Year 2019

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today released financial results for its full year ended December 31, 2019, as well as select corporate highlights. Among the highlights, the company reported its securing of a $15.0 million equity line with Oasis Capital, LLC, as well as its new subsidiary, Helomics, reaching milestone sequencing tumor cases in partnership with UPMC Magee. “2019 was not without its challenges for the entire healthcare technology industry, yet we continued to execute on our business model, making a synergistic acquisition and shoring up…

WednesdayApr 01, 2020 10:54 am

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Agreement with FLIR Systems Inc. (NASDAQ: FLIR) to Develop, Market and Distribute QuadSight(R) Vision System

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced its entry into an agreement with FLIR Systems Inc. (NASDAQ: FLIR), the world’s largest and leading commercial company specializing in the design and production of thermal imaging cameras, components and sensors. Under the agreement, the parties will establish a strategic cooperation plan for the development, marketing and distribution of Foresight’s QuadSight(R) vision system, combined with FLIR Systems’ infrared cameras, to a wide range of prospective customers. Foresight will exclusively purchase its thermal cameras from FLIR for all systems to be commercialized worldwide as part of…

WednesdayApr 01, 2020 10:10 am

NetworkNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integra Pharma Solutions Files for FDA Emergency Use Authorization for Rapid COVID-19 Test Kit

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that its wholly-owned subsidiary, Integra Pharma Solutions, has filed for an Emergency Use Authorization (“EUA”) with the U.S. Food and Drug Administration (“FDA”) in collaboration with its partnered manufacturer of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit. Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA Commissioner may, in an emergency, allow unapproved medical products or unapproved uses of approved medical products to be used in the diagnosis, treatment or prevention of serious or life-threatening diseases or when there…

WednesdayApr 01, 2020 10:00 am

NetworkNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Launch of Next Generation Line of Uniden Cellular Signal Boosters as Millions Migrate to Home Workspaces

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced its launch of the next generation line of Uniden(R) cellular signal boosters, helping families and businesses improve network connectivity for work, school and entertainment purposes. According to the update, the new home office line of cellular signal boosters, including the Uniden(R) U60C 4G and Uniden(R) U65C 4G, are designed to improve connectivity, especially as millions of workers migrate from office buildings to home workspaces during the Covid-19 crisis. “Millions of homes and businesses in North America suffer from weak cellular signals, resulting in missed calls, dropped calls and slow data speeds. This…

WednesdayApr 01, 2020 9:24 am

NetworkNewsBreaks – MCTC Holdings, Inc. (MCTC) Announces Full Integration of Lelantos Biotech’s Unique Technologies

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, this morning announced the full integration of Lelantos Biotech into MCTC. The company also provided an operational and product introduction update. MCTC announced the acquisition of Lelantos Biotech, Inc. in mid-February. Lelantos Biotech had previously been involved in various areas of cannabinoid and hemp infusion research and had closely collaborated with MCTC in relation to the filing of several patents in numerous hemp extract and cannabinoid delivery technologies. All the developments generated from this collaboration have been assigned to MCTC, and the rights…

TuesdayMar 31, 2020 12:35 pm

NetworkNewsBreaks – Jerrick Media Holdings Inc. (JMDA) Announces Timely Filing of 10-K, Strong Finish to 2019

Jerrick Media Holdings (OTCQB: JMDA) today announced the timely filing of its 10-K for the fiscal year ended December 31, 2019. “We had a strong finish to 2019. Development-wise, this year saw a series of significant reinforcements to the foundation of our company's flagship platform, Vocal,” Jerrick CEO Jeremy Frommer stated in the news release. “Product improvements for an enhanced content creation experience as well as systems and compliance updates have been of primary importance. Additionally, Vocal's creative community now benefits from the Vocal+ premium membership program. The company's Vocal for Brands offering continued to expand its client base, with…

TuesdayMar 31, 2020 12:05 pm

NetworkNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Announces Launch of PrintRite3D Production Series

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced its launch of the Printrite3D(R) Production Series that introduces the “Production Dashboard” and provides production managers with critical metrics, insight and actionable information during the production process. According to the update, the launch comes at a time when many predict a dramatic increase in the use of 3D printing of metal parts in response to COVID-19 and the effect of the pandemic on U.S. manufacturing, especially with manufacturers that rely on complex and lengthy supply chains. More agile and rapid in…

TuesdayMar 31, 2020 12:05 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Helomics’ Continued Progress Toward Developing AI-Driven Predictive Model of Ovarian Cancer

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced continued progress by its Helomics subsidiary toward the goal of developing an AI-driven predictive model of ovarian cancer (CancerQuest 2020). Per the update, CancerQuest2020 (CCQ2020) is focused on building an AI-driven model of ovarian cancer that will predict drug response and outcome. Predictive models embody the knowledge from these profiles, creating a “computational expert” or a “virtual patient” that can be queried. “Despite some headwinds imposed by the current COVID-19 pandemic, the Helomics team has been working diligently to…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks